For males, GONAL-f® has been approved in more than 80 countries worldwide, including Japan, for gonadal dysfunction associated with absence of sperm in the semen or male hypogonadotropic hypogonadism. In certain markets where GONAL-f® is approved for this indication, the therapy needs to be in combination with human chorionic gonadotropin (hCG).
The information contained in these pages is intended for general reference only. It may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country. This information should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination.
US Residents should consult EMD Serono, Inc. for information on products approved for sale in the United States of America.